- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07713082
Therapeutic Exercise and Education for Low Back Pain
Therapeutic Exercise and Education for Patients With Non-Specific Low Back Pain in Primary Health Care: A Multicenter Clinical Trial
연구 개요
상태
정황
상세 설명
Study Protocol and Operational Description
- Rationale and Study Justification Despite updated clinical guidelines that prioritize active interventions, such as therapeutic exercise and pain education, these interventions are not widely implemented in primary care settings. The discrepancy between evidence and practice presents a clear opportunity for improvement. Adopting structured programs based on scientific evidence promotes a consistent, efficient approach aligned with the biopsychosocial model. Consequently, this clinical trial aims to generate high-quality evidence in the primary care context to evaluate the effectiveness and efficiency of these care models. This will facilitate their implementation and advance us toward a more accessible and sustainable healthcare system.
- Study Design and Randomization This multicenter, randomized, single-blind, controlled clinical trial has a three-arm parallel group design. After recruitment at the Primary Care Physiotherapy Units (PCPUs) of the Castilla y León Health Service (SACYL) and informed consent is signed, participants with subacute or chronic nonspecific low back pain will be randomly assigned to one of three study groups.
Description of the Intervention Arms All active intervention protocols will be carried out over a period of eight weeks.
Online Therapeutic Exercise and Education (ETEO): Participants will engage in an eight-week, home-based therapeutic exercise program combined with pain neuroscience education. All content, instructional materials, and compliance monitoring will be delivered via a dedicated digital platform.
Face-to-Face Therapeutic Exercise and Education (ETEP): Participants will receive the same 8-week exercise and education curriculum through in-person, group sessions at participating PCPUs.
Conventional Treatment (CT): Participants will receive standard physiotherapy care as routinely provided within the public regional health service framework.
- Assessment Timeline and Outcome Measures Blinded evaluators will perform data collection and clinical measurements at three specific time points: baseline (T0), immediately post-intervention at eight weeks (T1), and at the three-month long-term follow-up (T2).
Primary Outcome Measure: Functional disability, quantified using the Oswestry Disability Index (ODI).
- Secondary Outcome Measures: Pain intensity, activity avoidance, pain catastrophizing, kinesiophobia, anxiety and depression symptoms, health-related quality of life, patient beliefs/knowledge regarding low back pain, and overall satisfaction with the intervention.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Héctor Hernández-Lázaro, PhD
- 전화번호: 38841 +34975220850
- 이메일: hector.hernandez.lazaro@uva.es
연구 연락처 백업
- 이름: Luis Ceballos-Laita, PhD
- 전화번호: +34975129100
- 이메일: luis.ceballos@uva.es
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion criteria:
- Patients with non-specific low back pain, aged 18 years or older.
- Pain duration of more than six weeks
- Onset or modification of low back pain with maintenance of positions and/or movements
- Presenting a mild-to-moderate level of disability, as determined by the Oswestry Disability Index (ODI) questionnaire.
- Presence of limitations or symptoms in at least two range of motion (ROM) or coordination assessment tests, as described in clinical guidelines:
- Lumbar and/or hip range of motion (ROM) measured with inclinometry Prone instability test
Presence of aberrant movements:
- Painful arc with flexion or return from flexion
- Instability catch
- Gower sign
- Reversal of lumbopelvic rhythm
- Strength and endurance of the abdominal musculature
- Email access and a device with an internet connection are required.
- Availability and willingness to participate in all study sessions.
Exclusion criteria:
- Presence of acute, nociplastic, radicular, and/or referred pain
- Presence of red flags
- Previous surgeries in the spine, pelvis, or hip
- Presence of concomitant cardiovascular, neurological, endocrine, or immune pathologies that prevent physical activity
- Presence of psychiatric disorders
- Pregnancy
- Having received physiotherapy treatment, analgesic blocks, corticosteroid injections, or any other type of intervention within the last three months
- Changes in lifestyle habits, work conditions, or physical activity levels within the last three months
- Inability to meet the program's physical or cognitive demands during the eight weeks
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Online Therapeutic Exercise and Education Group
Participants will carry out an eight-week protocol consisting of education on managing the condition and therapeutic exercises for the lumbopelvic and abdominal muscles.
This will be performed progressively.
All exercises will be performed at a perceived exertion level of 6-7 out of 10, leaving approximately three repetitions in reserve per exercise.
If exertion values are lower, the exercise intensity will increase.
If the intensity exceeds 7, the exercise intensity will decrease.
Elastic bands and exercise variations will be used to achieve this.
Rest periods between sets and exercises will be 1.5 minutes.
These sessions will be carried out synchronously online using the Google Meets platform.
This allows the physiotherapist to supervise and guide four to six participants per group online.
|
This intervention consists of applying a therapeutic exercise protocol to the lumbopelvic and abdominal muscles. The included exercises are:
Exercises will be performed at an effort level of 6-7/10 (rate of perceived exertion), leaving three repetitions in reserve per exercise. Participants will perform four to six sets of 15 repetitions for each exercise, with two sessions conducted per week. Rest periods between sets and exercises will be 1.5 minutes. Participants will receive four weekly education sessions on self-management of low back pain during the first four weeks of the intervention. The contents of these sessions will be as follows:
|
|
실험적: Face-to-Face Therapeutic Exercise and Education Group
This group will receive the same educational protocol for condition management and therapeutic exercise as the previous one, but it will be carried out in a face-to-face group format supervised by a physiotherapist from the Primary Care Physiotherapy Units.
|
This intervention consists of applying a therapeutic exercise protocol to the lumbopelvic and abdominal muscles. The included exercises are:
Exercises will be performed at an effort level of 6-7/10 (rate of perceived exertion), leaving three repetitions in reserve per exercise. Participants will perform four to six sets of 15 repetitions for each exercise, with two sessions conducted per week. Rest periods between sets and exercises will be 1.5 minutes. Participants will receive four weekly education sessions on self-management of low back pain during the first four weeks of the intervention. The contents of these sessions will be as follows:
|
|
활성 비교기: Conventional Treatment Group
This group will undergo interventions typically applied in primary care physiotherapy units, including electrotherapy and exercise training. The following electrotherapy techniques will be applied:
|
Participants will receive a total of 16 sessions of usual care, two per week. The interventions included are as follows:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in disability level
기간: From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
Functional disability will be measured using the Spanish version of the Oswestry Disability Index (ODI).
The ODI is a 10-item questionnaire with six response options each (0-5 points) that assess limitations in activities of daily living.
|
From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Changes in Pain Intensity
기간: From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
The Spanish version of the Numeric Pain Rating Scale (NPRS), which is widely used in populations with low back pain, will be used to assess pain during the last week and pain during movement.
|
From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
|
Changes in Activity Avoidance Attitudes
기간: From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
Activity avoidance will be assessed using the Spanish version of the Fear-Avoidance Beliefs Questionnaire (FABQ).
The questionnaire consists of 16 items distributed across two subscales: physical activity and work.
|
From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
|
Change in Catastrophizing Level
기간: From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
Catastrophizing will be measured using the Spanish version of the Pain Catastrophizing Scale (PCS), which consists of 13 items that assess rumination, magnification, and helplessness.
Each item is scored from 0 to 4, resulting in a total score ranging from 0 to 52.
Higher values reflect greater catastrophizing.
|
From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
|
Changes in Self-Efficacy Levels
기간: From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
Self-efficacy and confidence in performing back-related activities will be assessed using the Low Back Activity Confidence Scale (LoBACS).
The LoBACS consists of 15 items that cover a wide range of activities commonly experienced by patients.
The scale is organized into three subscales: functional self-efficacy (confidence in performing functional activities), self-regulatory self-efficacy (confidence in coping with low back pain), and exercise self-efficacy (ability to overcome barriers to regular exercise).
Scores on this scale range from 0 to 100, with higher scores indicating a greater level of self-efficacy.
|
From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
|
Changes in Anxiety and Depression
기간: From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
Anxiety and depression will be assessed using the Spanish version of the Hospital Anxiety and Depression Scale (HADS), which has 14 items divided into two subscales: anxiety and depression.
Each item is scored from 0 to 3, and the total possible score per subscale is 21.
Higher scores indicate greater symptomatology.
|
From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
|
Changes in kinesiophobia levels
기간: From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
Kinesiophobia will be measured using the Spanish version of the 11-item Tampa Scale for Kinesiophobia (TSK-11).
Each item is scored on a Likert scale from 1 to 4. The total score ranges from 11 to 44; higher values indicate a greater fear of movement.
|
From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
|
Change in quality of life
기간: From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
Health-related quality of life will be assessed using the Spanish version of the EuroQol-5D (EQ-5D).
The EQ-5D includes five dimensions - mobility, self-care, usual activities, pain/discomfort, and anxiety/depression - with different levels of severity.
It also includes a visual analog scale (VAS) ranging from 0 to 100.
The utility index is calculated based on the responses provided, with higher values indicating a better health status.
|
From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
|
Changes in Knowledge and Beliefs about Low Back Pain
기간: From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
The Back Pain Knowledge and Beliefs Survey (BacKS) will be used to assess knowledge and beliefs about low back pain.
BacKS is a patient-reported outcome measure designed to evaluate the level of evidence-based knowledge and beliefs associated with low back pain.
The survey consists of 20 items scored on a Likert scale from 1 to 5, where 1 corresponds to "strongly disagree" and 5 corresponds to "strongly agree."
Total scores range from 20 to 100; higher scores indicate greater knowledge and beliefs aligned with scientific evidence.
The questionnaire has a two-dimensional structure, with one factor related to biomedical knowledge (nine items) and another related to self-care knowledge (11 items).
|
From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
|
Level of satisfaction with treatment administered
기간: From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
Overall perception of change will be assessed using the Global Rating of Change (GROC) in the version used for the Spanish population.
The GROC is an ordinal scale that typically ranges from negative values (worsening) to positive values (improvement), with a neutral point (no change).
The score reflects the patient's perception of their clinical evolution.
|
From the time of enrollment in the study through the end of treatment (eight weeks) and the follow-up period (12 weeks after the end of treatment).
|
공동 작업자 및 조사자
간행물 및 유용한 링크
일반 간행물
- Delitto A, George SZ, Van Dillen L, Whitman JM, Sowa G, Shekelle P, Denninger TR, Godges JJ; Orthopaedic Section of the American Physical Therapy Association. Low back pain. J Orthop Sports Phys Ther. 2012 Apr;42(4):A1-57. doi: 10.2519/jospt.2012.42.4.A1. Epub 2012 Mar 30.
- George SZ, Fritz JM, Silfies SP, Schneider MJ, Beneciuk JM, Lentz TA, Gilliam JR, Hendren S, Norman KS. Interventions for the Management of Acute and Chronic Low Back Pain: Revision 2021. J Orthop Sports Phys Ther. 2021 Nov;51(11):CPG1-CPG60. doi: 10.2519/jospt.2021.0304.
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
하부 요통에 대한 임상 시험
-
FibroGenAstraZeneca; Astellas Pharma Inc종료됨빈혈증 | 기본 MDS(Very Low, Low 또는 Intermediate IPSS-R with미국, 호주, 벨기에, 독일, 이스라엘, 이탈리아, 대한민국, 러시아 연방, 스페인, 영국, 프랑스, 칠면조, 캐나다, 덴마크, 인도, 폴란드
-
Bingol UniversityAtaturk University아직 모집하지 않음수술 전 불안 | 두려움 | PAIN
-
Cancer Institute and Hospital, Chinese Academy...모병내장 위기로 인해 복잡한 HER2-LOW 절제 불가능한/전이성 유방암중국
-
Weill Medical College of Cornell UniversityNew York University; National Center for Complementary and Integrative Health (NCCIH)모병
-
Shanghai Henlius Biotech모병HER2-LOW 호르몬 수용체 양성 유방암중국
-
Université Victor Segalen Bordeaux 2Nanox International Laboratory (Belgique)완전한
-
Yeon Hee ParkHelsinn Healthcare SA초대로 등록T-DXD로 치료 한 HER2 양성 진행 유방암 환자 | T-DXD로 치료 한 HER2-LOW 진행된 유방암 환자대한민국
-
Istanbul University모병Masticatory Muscle Pain | 근시 통증 증후군 (MP)칠면조
-
Eisai Inc.완전한LEC(Low Emetogenic Chemotherapy)를 받기 위해 확인된 악성 질환이 있는 환자 또는 LEC의 마지막 주기 동안 최소한 메스꺼움 및 구토를 경험한 환자미국
Therapeutic Exercise에 대한 임상 시험
-
Kessler FoundationBrainQ Technologies Ltd.아직 모집하지 않음뇌졸중 | 만성 뇌졸중 환자
-
Riphah International University완전한
-
Cukurova University완전한
-
University of TorontoUniversity Health Network, Toronto; University of Western Ontario, Canada; Institute for... 그리고 다른 협력자들완전한
-
The Hong Kong Polytechnic University완전한
-
VA Salt Lake City Health Care System빼는
-
University of California, Los AngelesAga Khan University아직 모집하지 않음영양실조, 아동 | 어린 시절의 심각한 급성 영양실조 | 신경인지, 어린이파키스탄
-
Nanjing University of Traditional Chinese Medicine모집하지 않고 적극적으로